Dexrazoxane mitigates long-term cardiotoxicities of doxorubicin for young patients
In an interview with Healio, Erin Mobley, Ph.D., discussed her study on the cardioprotective effects of dexrazoxane in pediatric cancer survivors.
Posts tagged as
Erin Mobley
Erin Mobley, Ph.D., receives 2025 Merit Award from ASCO Foundation Conquer Cancer
The award recognizes her research on cardiac function after doxorubicin and dexrazoxane.
Cancer Survivor Month: How Dr. Erin Mobley’s journey shaped her career
Erin Mobley's childhood journey shaped her career pathway as a cancer researcher.
